Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1
Ocular Therapeutix delivers FDA-approved eye therapies and devices, supported by a pipeline targeting multiple ocular diseases.
Open original sourceLoading market dashboard
Ocular Therapeutix delivers FDA-approved eye therapies and devices, supported by a pipeline targeting multiple ocular diseases.
Open original source